English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

A new series of 1-(4-methoxyphenyl)- N -substituted phenyl-1 H -1,2,3-triazole-4-carboxamide derivates ( 4A–4N ) have been synthesized in excellent yields and structures were characterized by spectral techniques like  1 H-NMR,  13 C-NMR, LC-MS, and FT-IR. The newly synthesized derivatives were evaluated for anticancer activity against breast cancer cell lines MCF-7 and MDA-MB-231. Among them, compound  4H  (IC 50  = 13.11 and 23.61 μM) and compound  4M  (IC 50  = 11.55–31.87 μM) shows good cytotoxicity activity toward both cell line, while compounds  4B  (IC 50  = 9.48 μM),  4I  (IC 50  = 7.11 μM), and  4J  (IC 50  = 8.27 μM) showed promising cytotoxicity against MCF-7 cell line as compared with standard (Doxorubicin). Also explored docking study with binding mode of interactions and active site in EGFR tyrosinse (PDB ID: 2J5F) proteins and molecular docking study shows very good interaction with the tyrosine kinase active site. In addition to this targeted compounds were studied the pharmacokinetics and the compounds were follow Lipinski’s rule of five as well as compounds have acceptable good drug-likeness score properties.

synthetic communications

Design, synthesis, cytotoxicity, and molecular docking studies of 1-(4-methoxyphenyl)- N -substituted phenyl-1 H -1,2,3-triazole-4-carboxamide derivatives